Screening for gastrointestinal and pancreatic diseases

Area of Science:

• Gastroenterology
• Clinical Diagnostics
• Pancreatic Diseases

Background:

• Chronic gastrointestinal and pancreatic diseases present with nonspecific symptoms like abdominal pain and diarrhea, complicating diagnosis.
• Stool assays offer higher sensitivity than serum assays but have specific limitations for healthcare providers.
• Current diagnostic algorithms recommend stool testing for inflammatory, watery (osmotic), and malabsorptive conditions.

Purpose of the Study:

• To discuss stool-based screening tests for chronic gastrointestinal and pancreatic diseases.
• To review the major disorders screened by these tests and their clinical performance.
• To highlight assay and sample limitations relevant to laboratory and clinical practice.

Main Methods:

• Review of various stool-based screening tests.
• Analysis of clinical performance data for these assays.
• Discussion of limitations associated with stool assays and sample collection.

Main Results:

• Stool testing is a valuable tool for screening chronic gastrointestinal and pancreatic disorders.
• Understanding the benefits and limitations of stool assays is essential for effective use.
• Specific tests can identify inflammatory, watery (osmotic), and malabsorptive conditions.

Conclusions:

• Stool testing provides critical diagnostic, prognostic, and treatment response information.
• Awareness of assay and sample limitations enhances the utility of stool-based diagnostics.
• Effective interpretation requires collaboration between laboratories and clinicians.